Molina director granted 170 MOH shares

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare, Inc. director Francis S. Soistman Jr. received a grant of 170 shares of common stock on May 6, 2026 under the company’s 2025 Incentive Plan, as a prorated quarterly director award. The grant was valued at the closing price of $197.44 per share on that date, and following this award he directly holds 670 shares of Molina Healthcare common stock.

Insider Trade Summary

Grant/Award: 170 shares

Grant/Award 1 txn

Insider SOISTMAN FRANCIS S JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	170	$197.44	$34K

Holdings After Transaction: Common Stock — 670 shares (Direct)

Footnotes (3)

F1. Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director.
F2. Represents the prorated quarterly director grant. Mr. Soistman was elected as a director on May 6, 2026.
F3. Represents the closing price of the Issuer's common stock on May 6, 2026.

Key Figures

Shares granted: 170 shares Grant price per share: $197.44 per share Shares held after grant: 670 shares

3 metrics

Shares granted 170 shares Director stock grant on May 6, 2026

Grant price per share $197.44 per share Closing price on May 6, 2026

Shares held after grant 670 shares Total direct holdings following transaction

Key Terms

2025 Incentive Plan, prorated quarterly director grant, Common Stock

3 terms

2025 Incentive Plan financial

"Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director."

prorated quarterly director grant financial

"Represents the prorated quarterly director grant."

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Molina Healthcare (MOH) report for Francis S. Soistman Jr.?

Molina Healthcare reported that director Francis S. Soistman Jr. received a grant of 170 shares of common stock. The award was issued under the 2025 Incentive Plan as compensation for his director services, reflecting a prorated quarterly director grant upon his election.

On what date did Francis S. Soistman Jr. receive his Molina Healthcare (MOH) stock grant?

Francis S. Soistman Jr. received the stock grant on May 6, 2026. This date aligns with his election as a director, and the grant represents a prorated quarterly director award under Molina Healthcare’s 2025 Incentive Plan for board service compensation.

How many Molina Healthcare (MOH) shares were granted to Francis S. Soistman Jr. and at what price?

He was granted 170 shares of Molina Healthcare common stock at a value of $197.44 per share. That price represents the closing market price of the company’s common stock on May 6, 2026, the date of his director election and grant.

What is Francis S. Soistman Jr.’s Molina Healthcare (MOH) shareholding after this grant?

After the grant, Francis S. Soistman Jr. directly holds 670 shares of Molina Healthcare common stock. This total includes the newly awarded 170 shares received on May 6, 2026, as a prorated quarterly director grant under the 2025 Incentive Plan.

Was the Molina Healthcare (MOH) transaction for Francis S. Soistman Jr. a market purchase or a compensation grant?

The transaction was a compensation-related stock grant, not a market purchase. It is classified as a grant or award acquisition under the 2025 Incentive Plan, issued in connection with his services as a director and his election on May 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/08/2026 - 04:36 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SOISTMAN FRANCIS S JR

(Last)

(First)

(Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH

CALIFORNIA

90802

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/06/2026		A⁽¹⁾		170⁽²⁾	A	$197.44⁽³⁾	670	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director.

2. Represents the prorated quarterly director grant. Mr. Soistman was elected as a director on May 6, 2026.

3. Represents the closing price of the Issuer's common stock on May 6, 2026.

Remarks:

	Jeff D. Barlow, power of attorney for Francis Soistman	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR